What is Neolight?
NeoLight LLC is at the forefront of developing innovative neonatal care products designed to enhance the health and well-being of newborns. Their product portfolio includes the advanced Skylife Neonatal Phototherapy System for jaundice treatment, sophisticated brain monitoring solutions, and essential ocular screening tools. Complementing these are non-nutritive sucking aids and comprehensive educational resources for healthcare professionals. NeoLight's mission is to empower hospitals and healthcare providers with superior tools, fostering empathy-driven innovation to improve neonatal health outcomes globally.
How much funding has Neolight raised?
Neolight has raised a total of $7.8M across 3 funding rounds:
Angel/Seed
$600K
Debt
$150K
Unspecified
$7M
Angel/Seed (2016): $600K, investors not publicly disclosed
Debt (2020): $150K led by PPP
Unspecified (2020): $7M supported by Ben Roethlisberger, Honor Health Systems, Ashley Roethlisberger, and Dignity Health
Key Investors in Neolight
Dignity Health
Dignity Health, a prominent healthcare system, likely invests in companies that align with improving patient care and health outcomes, particularly within their network of hospitals and medical facilities.
Honor Health Systems
Honor Health Systems, as a healthcare provider, would typically invest in technologies and solutions that enhance medical services and patient care, especially within their operational scope.
Ben Roethlisberger
Ben Roethlisberger, a notable public figure, may be investing in Neolight due to a personal interest in healthcare innovation or a strategic partnership opportunity.
What's next for Neolight?
With a recent major strategic investment and substantial enterprise-level backing, Neolight is poised for significant expansion and product development. The company's focus on critical neonatal care areas such as phototherapy and brain monitoring suggests a strategic direction towards deepening its impact in NICU environments. Future endeavors will likely involve scaling production, enhancing existing technologies, and potentially introducing new solutions to address unmet needs in newborn health. This strategic financing will be instrumental in solidifying Neolight's position as a leader in neonatal innovation.
See full Neolight company page
